1-ETHYL-7-(2-METHYL-6-(1H-1,2,4-TRIAZOL-3-YL)PYRIDIN-3-YL)-3,4-DIHYDROPYRAZINO[2,3-B]PYRAZI… Grant EP-2986299-B1 European Patent Office 29 Mar 2023
METHODS AND COMPOSITIONS FOR TARGETED DELIVERY OF ACTIVE AGENTS AND IMMUNOMODULATORY… Application US-20210147544-A1 United States of America 20 May 2021
Treatment of cancer with dihydropyrazino-pyrazines Application US-10183019-B2 United States of America 22 Jan 2019
Treatment of cancer with dihydropyrazino-pyrazines Grant US-9630966-B2 United States of America 25 Apr 2017